An official website of the United States government

Citation
Kaysen, George (2016). A Cohort Study to Investigate the Value of Exercise in ESRD/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD (ACTIVE/ADIPOSE) (Version 1) [Dataset] NIDDK Central Repository. https://doi.org/10.58020/4nz9-tq14
Data Availability Statement
Data from the A Cohort Study to Investigate the Value of Exercise in ESRD/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD (ACTIVE/ADIPOSE) [(Version 1) https://doi.org/10.58020/4nz9-tq14] reported here are available for request at the NIDDK Central Repository (NIDDK-CR) website, Resources for Research (R4R), https://repository.niddk.nih.gov/.
Acknowledgement Statement
The ACTIVE/ADIPOSE study was conducted by the study investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The resources from the ACTIVE/ADIPOSE (https://doi.org/10.58020/4nz9-tq14) study reported here were supplied by NIDDK Central Repository (NIDDK-CR) and are available for request at https://repository.niddk.nih.gov. This manuscript was not prepared under the auspices of the ACTIVE/ADIPOSE study and does not necessarily reflect the opinions or views of the ACTIVE/ADIPOSE study, NIDDK-CR, or NIDDK.
Data Package Version
Version 1 (Updated on: May 27, 2016)
Resource Availability
  • Data Available for Request
  • Specimens Available for Request
Publications
Explore publications resulting from the use of study resources
View publications (0)

General Description

Characteristics associated with the phenotype of frailty include fatigue and reduced physiologic capacity in neurologic control, mechanical performance, and energy metabolism. Studies have shown that there is an increased risk of frailty in chronic disease populations, including patients with chronic kidney disease undergoing hemodialysis. Currently, little is known about the prevalence or the contributing factors of frailty among patients with this condition. The ACTIVE/ADIPOSE (a Cohort Study to Investigate the Value of Exercise in ESRD/Analyses Designed to Investigate the Paradox of Obesity and Survival in ESRD) study is a prospective, multicenter observational study designed to characterize the prevalence and progression of frailty among patients undergoing hemodialysis for end-stage renal disease (ESRD).

Patients at least 18 years of age who were on hemodialysis for at least three months were enrolled in the study. Participants were assessed using the validated Fried frailty index, which defines frailty as the presence of 3 or more criteria, including recent unintentional weight loss, reported exhaustion, low grip strength, slow walk speed, and low physical activity. Information was collected on participants’ demographics, medical history, activity status, and mood, and physical performance was assessed via tests of grip strength, walk speed, and body composition. Additionally, blood draws were conducted semi-annually for evaluation of nutrition, inflammation, and cardiac markers. All participants were followed for two years. Logistic regression models were used to estimate the association of nutrition, cardiovascular, and rehabilitation parameters with patient frailty.

Analyses showed that peripheral vascular disease and cardiac diseases, such as dysrhythmia, atrial fibrillation, tachycardia, pericarditis, and cardiac arrest, were associated with higher odds for frailty. In contrast, black race and higher serum albumin concentration were associated with lower odds for frailty. Among patients who met the Fried definition of frailty, 78% scored as frail on walk speed and 56% scored as frail on grip strength, the two measures of physical performance. The association of these sociodemographic and clinical risk factors with wasting in this cohort provides evidence for the prevalence of frailty in hemodialysis patients.

Objectives

The primary aim of the ACTIVE/ADIPOSE study is to characterize the prevalence and progression of frailty among patients undergoing hemodialysis for end-stage renal disease.

Outcome Measure

Logistic regression models were used to determine the associations between nutrition, cardiovascular, and rehabilitation factors with the frailty phenotype.

Eligibility Criteria

Patients of at least 18 years of age who spoke either English or Spanish, were on hemodialysis for at least three months, and gave informed consent were enrolled in the study.

Outcome

Analyses showed that peripheral vascular disease and cardiac diseases, such as dysrhythmia, atrial fibrillation, tachycardia, pericarditis, and cardiac arrest, were associated with higher odds for frailty. In contrast, black race and higher serum albumin concentration were associated with lower odds for frailty. Among patients who met the Fried definition of frailty, 78% scored as frail on walk speed and 56% scored as frail on grip strength, the 2 physical performance measures. The association of these sociodemographic and clinical risk factors with wasting in this cohort provides evidence for the prevalence of frailty in hemodialysis patients. There is a need for prospective testing of interventions to address wasting or other components of the frailty syndrome to determine whether frailty can be reversed and whether improvements in frailty are associated with improved survival.

Research Area

Obesity, Multidisciplinary Research, Kidney Disease

Study Type

Observational

Study Sites

14

Study Start Date

2009-07

Study End Date

2013-09

Condition

Cardiovascular Disorder, Chronic Kidney Disease, End Stage Renal Failure

Keywords

End-Stage Renal Disease, Kidney Disease, Renal Insufficiency

NIDDK Division

Division of Kidney, Urologic, and Hematologic Diseases

771
Participants

Target Population
Adults, Dialysis Patients

Public Documents Table
Document Name
Description
Document Type
File Format
Compliance
Download

Non-Public Documents (2)
Non-Public Documents Table
Document Name
Description
Document Type
File Format
Datasets (34)
Datasets Table
Dataset Name
Description
# of Records
# of Variables
File Format(s)
Specimens (31,813)
Specimens Table
Specimen
Count
Serum22898
Whole Blood8915